XIV Eurasian Hematology-Oncology Congress - EHOC 2023

 

XIV Eurasian Hematology-Oncology Congress - EHOC 2023
A

How I Manage Late Relapsed Myeloma With T-Cell Engaging Therapy

By XIV Eurasian Hematology-Oncology Congress - EHOC 2023 FEATURING Alessandra Romano
By XIV Eurasian Hematology-Oncology Congress - EHOC 2023 FEATURING Alessandra Romano
14 views
February 15, 2024
Comments 0
Login to view comments. Click here to Login
Myeloma
10:39

Real-World Treatment Patterns and Outcomes in Patients With R/R MM W…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Ö. Pektaş

10 views
08:04

Future Perspectives on the Management of Myeloma: Cure or Longterm D…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

R. Magalhaes

38 views
10:04

Debates in Myeloma: Smoldering Myeloma Should NOT Be Treated

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

E. Terpos

29 views
09:46

Debates in Myeloma: Smoldering Myeloma Should Be Treated

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

C. Cerchione

26 views
21:44

How I Manage Late Relapsed Myeloma With T-Cell Engaging Therapy

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Romano

14 views
07:42

Case Presentation: R/R Myeloma With Extramedullary Plasmacytoma Invo…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Yeşilaltay

13 views
13:54

MRD in the Era of Modern MM Therapies

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

R. Magalhaes

169 views
24:29

How I Treat R/R MM With CAR-T and Bispecific Antibodies

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

C. Cerchione

160 views
07:23

IKEMA Trial Final Updates: Carfilzomib/Dex +/- Isatuximab in Patient…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

E. Güder Arslan

24 views